A. Bandaranayake

发表

Daedalus: a robust, turnkey platform for rapid production of decigram quantities of active recombinant proteins in human cell lines using novel lentiviral vectors

R. Strong, C. Correnti, A. Bandaranayake, 2011, Nucleic acids research.

Publisher Correction: Mammalian display screening of diverse cystine-dense peptides for difficult to drug targets

Zachary R Crook, P. Bradley, D. Baker, 2018, Nature Communications.

In vitro activity of antimicrobial peptide CDP-B11 alone and in combination with colistin against colistin-resistant and multidrug-resistant Escherichia coli

A. Bandaranayake, D. Call, James M Olson, 2021, Scientific Reports.

Recent advances in mammalian protein production

Steven C Almo, S. Almo, A. Bandaranayake, 2014, FEBS letters.

Engineering and functionalization of large circular tandem repeat protein nanoparticles

P. Bradley, B. Shen, B. Stoddard, 2020, Nature Structural & Molecular Biology.

Ex silico engineering of cystine-dense peptides yielding a potent bispecific T cell engager

Emily J. Girard, Zachary R Crook, M. Brusniak, 2022, Science Translational Medicine.

Screening, large-scale production, and structure-based classification for cystine-dense peptides

Damon H. May, J. Olson, M. Brusniak, 2018, Nature Structural & Molecular Biology.

Phosphorylation of the CARMA1 linker controls NF-kappaB activation.

A. Bandaranayake, D. Rawlings, J. Pomerantz, 2005, Immunity.

Proximal signals controlling B-cell antigen receptor (BCR) mediated NF-kappaB activation.

A. Bandaranayake, D. Rawlings, Miguel E. Moreno-García, 2006, Advances in experimental medicine and biology.

Reduced c-myc Expression Levels Limit Follicular Mature B Cell Cycling in Response to TLR Signals1

A. Bandaranayake, D. Rawlings, Sarah F. Andrews, 2009, The Journal of Immunology.

to TLR Signals Follicular Mature B Cell Cycling in Response Expression Levels Limit myc Reduced c-Andrews

A. Bandaranayake, D. Rawlings, A. Meyer‐Bahlburg, 2022 .

Siderocalin/Lcn2/NGAL/24p3 Does Not Drive Apoptosis Through Gentisic Acid Mediated Iron Withdrawal in Hematopoietic Cell Lines

R. Strong, C. Correnti, A. Bandaranayake, 2012, PloS one.

Phosphorylation of the CARMA1 Linker Controls NF-κB Activation

David J. Rawlings, A. Bandaranayake, D. Rawlings, 2005 .

Mammalian display screening of diverse cystine-dense peptides for difficult to drug targets

P. Bradley, J. Olson, M. Brusniak, 2017, Nature Communications.

MAGUK-Controlled Ubiquitination of CARMA1 Modulates Lymphocyte NF-κB Activity

David J. Rawlings, A. Bandaranayake, D. Rawlings, 2009, Molecular and Cellular Biology.

Simultaneous Multiple Interaction T-cell Engaging (SMITE) Bispecific Antibodies Overcome Bispecific T-cell Engager (BiTE) Resistance Via CD28 Co-Stimulation

J. Olson, C. Correnti, A. Bandaranayake, 2017, Leukemia.

Immunotherapeutic Targeting of Mesothelin Positive Pediatric AML Using Bispecific T Cell Engaging Antibodies

S. Meshinchi, C. Correnti, A. Bandaranayake, 2021, Cancers.

Circumventing colistin resistance by combining colistin and antimicrobial peptides to kill colistin-resistant and multidrug-resistant Gram-negative bacteria

A. Bandaranayake, D. Call, Jason Price, 2020, Journal of global antimicrobial resistance.

Engineering and functionalization of large circular tandem repeat protein nanoparticles

P. Bradley, B. Shen, B. Stoddard, 2020, Nature Structural & Molecular Biology.

Mammalian display screening of diverse cystine-dense peptides for difficult to drug targets

P. Bradley, D. Baker, J. Olson, 2017, Nature Communications.

Novel mesothelin antibodies enable crystallography of the intact mesothelin ectodomain and engineering of potent, T cell-engaging bispecific therapeutics

S. Meshinchi, R. Strong, C. Correnti, 2023, Frontiers in Drug Discovery.

Recent advances in mammalian protein production

S. Almo, A. Bandaranayake, 2014, FEBS letters.